- CCI approves GSK-Pfizer consumer healthcare JV 24 May 2019
- Hindustan Unilever to merge GSK Consumer Healthcare 03 December 2018
- Unilever, Nestle in close fight to acquire Horlicks from GSK 28 November 2018
- Emma Walmsley named Glaxo's first woman CEO 20 September 2016
- Apple, GlaxoSmithKline in diagnostic platform pact 19 July 2016
- Novartis-GSK business deal gets CCI nod 23 December 2014
- GSK abandons sale of older drugs portfolio 05 December 2014
- GlaxoSmithKline's $1.57-bn restructuring to hit US jobs 04 December 2014
- Ebola virus gives birth to a new vaccine 28 November 2014
- GlaxoSmithKline to launch first-ever malaria vaccine 26 July 2014
- GSK's former China head charged with bribery 14 May 2014
- Novartis AG, GSK in $23-bn assets swap deal 22 April 2014
- GSK launches probe into unethical conduct in Iraq 09 April 2014
- GSK spends $1.05 bn to raise stake in Indian arm 11 March 2014
- GlaxoSmithKline to stop paying doctors for product promotion 17 December 2013
- Glaxo announces open offer to hike stake in Indian arm 16 December 2013
- GSK sells thrombosis drugs to Aspen for $1.13 billion 01 October 2013
- GSK in talks to sell Lucozade, Ribena soft drinks to Suntory 06 September 2013
- India revokes patent of GSK's breast cancer drug Tykerb 02 August 2013
- China detains four senior GSK employees over bribery 15 July 2013
- China launches probe on GSK over price fixing 05 July 2013
- GSK Pharma net up at Rs138.5 cr; proposes 500 per cent dividend 19 February 2013
- GSK ups stake in Indian arm to 72.5% in a Rs4,800-cr stock deal 05 February 2013
- GSK, MD Anderson Cancer Center to develop new cancer drugs 10 December 2012
- GSK Consumer Healthcare share buyback opens on 17 January 05 December 2012
- Glaxo makes open offer to hike stake in Indian arm 26 November 2012
- GSK to sell Australian generic portfolio to Aspen Pharma 16 August 2012
- Aspen to buy GSK's international OTC brands 20 April 2012
- GSK to sell most European OTC drugs to Omega Pharma 15 March 2012
- GSK repatriating funds daily from European operations 08 February 2012
- Patented drugs overpriced, admits Glaxo CEO Witty 28 September 2011
- GlaxoSmithKline acquires rights to Parkinson's drug from Impax 16 December 2010
- GlaxoSmithKline plans to acquire China's Nanjing MeiRui Pharma 02 December 2010
- GSK plans to invest £500 million in new projects in UK 01 December 2010
- GlaxoSmithKline expands research collaboration with Brazil's Fiocruz 13 November 2010
- Regulators in EU, US "kill" Glaxo's diabetes drug Avandia 24 September 2010
- GSK sues Roche over Genentech's cancer drug patent infringement 23 September 2010
- UK regulator moots withdrawing GSK's Avandia drug from UK market 06 September 2010
- GSK investigates Pandermix link to chronic sleep disorder 04 September 2010
- GlaxoSmithKline net sales up 9 per cent 26 July 2010
- GlaxoSmithKline: truth is a bitter pill 14 July 2010
- GSK Q1 earnings surge on swine flue vaccine 29 April 2010
- GSK, Isis Pharma in RNA therapeutics licencing pact 31 March 2010
- GlaxoSmithKline on the prowl for acquisitions in India 09 March 2010
- GlaxoSmithKline forced to remove zinc from denture cream products 22 February 2010
- GSK Pharma posts Q4 PAT of Rs103.59 crore 16 February 2010
- GlaxoSmithKline may follow AstraZeneca in axing jobs: report 01 February 2010
- GSK inching closer to deal with Dr Reddy's? 08 January 2010
- DCGI asks GSK to withdraw promotional campaign 26 December 2009
- GlaxoSmithkline suspends operations at Andhra unit 11 December 2009
- Glaxo targets emerging markets for acquisitions, tie-ups 11 December 2009
- GSK receives orders for 440 million doses of H1N1 vaccine 06 October 2009
- Glaxo seeking stake in Dr Reddy's: report 18 September 2009
- GSK to test swine flu vaccine in India at selected sites 03 September 2009
- Glenmark faces GSK patent challenge in US over malaria drug 18 August 2009
- GlaxoSmithKline retains Mahindra Satyam for IT deal 10 July 2009
- GSK signs drug pact with Chroma Therapeutics 24 June 2009
- Glaxo ties up with Dr Reddy's for emerging markets 15 June 2009
- Wockhardt to launch ulcer drug Ranitidine in the US 26 February 2009
- Glaxo buys UCB patents 24 January 2009
- GSK to focus on modern retail trade 31 October 2008
- Glaxo acquires oral care product Biotene for $170 million 22 October 2008
- Glaxo to cut 350 R&D jobs in drug research revamp 11 June 2008
- GlaxoSmithKline acquires Sirtris Pharmaceuticals 24 April 2008
- Women's Horlicks from GSK Consumer 30 January 2008
- GSK to launch cancer drug Tykerb in India 10 November 2007
- GlaxoSmithKline pharmaceuticals divests fine 26 July 2007
- Ranbaxy-GSK alliance to develop respiratory drug 02 April 2007
- Ranbaxy-Glaxo extend pact 07 February 2007
- Glaxo moves court against Ranbaxy''s generic drug 03 February 2007
- Glaxo buys Genmab's leukemia drug for record $2.1 billion 19 December 2006
- GSK withdraws patent plea for AIDS drug Combivir 21 August 2006
- GlaxoSmithKline Q2 net falls 12 per cent 27 July 2006
- GSK India announces buyback 15 March 2005
- On the clinical trial trail 11 March 2005
- GlaxoSmithKline to locate first Indian vaccine plant at Nashik 23 February 2005
- GlaxoSmithKline Q4-05 up at 61.4% 17 February 2005
- GSK sells worli plot for Rs107.6 crores 24 April 2004
- GlaxoSmithKline declares second interim dividend of 37% 21 December 2002
- Glaxo SmithKline defers merger with Burroughs Wellcome 09 December 2002
- Ranbaxy refutes Glaxo’s charge of stealing 24 August 2002
- Glaxo SmithKline to sue Novartis, Ranbaxy 23 August 2002
- GlaxoSmithkline to launch new products 12 March 2002
- Pharma sector fared well in 2001 28 December 2001
- Pharma companies in talks with MIDC 13 December 2001
- Iodex goes to SmithKline Healthcare 26 November 2001
- GlaxoSmithKline''s plans for Affymax runs aground 31 July 2001
- GlaxoSmithKline to sell-off Affymax 21 March 2001
- GlaxoSmithKline strikes licensing deal with Merck 16 February 2001
